Small Molecule CDMOs

Groupe SYNERLAB CDMO

France

Groupe SYNERLAB (now operating as Meribel Pharma Solutions) is a mid-size European CDMO with an integrated network of manufacturing sites across Europe, providing end-to-end services from API manufacturing through finished dosage forms. The company specializes in sterile multidoses, sterile and non-sterile lyophilized products, sachets, stick packs, oral solid dose, liquids, and semi-solids.

Grünenthal PRO (Grünenthal CDMO)

Chile

Duplicate entry of Grunenthal PRO (company ID 8756785b). Grunenthal PRO is the contract manufacturing arm of Grunenthal Group, operating five specialized plants with vertically integrated manufacturing from active substance to finished products. Approximately 50% of total production is for third-party clients across 100+ countries.

Grupo Azevedos (Sofarimex)

Portugal

Grupo Azevedos, operating through its Sofarimex manufacturing unit, is a Portuguese CDMO specializing in freeze-dried injectables and sterile eye drops, with over 20 years of contract manufacturing experience. The company manufactures pharmaceutical medicines and health products for third parties across non-sterile solid, semi-solid, and liquid forms, as well as sterile products, and holds manufacturing licenses from INFARMED and multiple international authorities.

Grupo Medinfar

Portugal

Grupo Medinfar is a Portuguese pharmaceutical company founded in 1970, with an industrial unit that has provided contract manufacturing services for over 20 years. The company manufactures non-sterile solid, semi-solid, and liquid pharmaceutical products for third-party clients, offering turnkey and custom services including bulk manufacturing, packaging, analytical release, and scale-up support.

Huazhong Pharmaceutical Co., Ltd. (HPC) is a Chinese pharmaceutical company established in 1995, manufacturing APIs, intermediates, and finished dosage forms including tablets. The company has GMP manufacturing sites with capabilities in both biological transformations and chemical synthesis, producing products such as albendazole, isoniazid, paracetamol, and nifedipine tablets.

ICE Pharma is a niche API and specialty ingredients CDMO founded in 1949 in Italy, focused on the development and manufacture of bile acid derivatives including Ursodeoxycholic Acid (UDCA). The company operates a fully vertically integrated manufacturing network of 7 global production facilities and provides CDMO services for both APIs and finished dosage forms, as well as custom carbohydrate chemistry through its Dextra unit.

IDI Integratori Dietetici Italiani srl is an Italian pharmaceutical company engaged in the development and manufacturing of pharmaceutical products, dietary supplements, and medical devices. The company has FDA-registered facilities and produces a range of products including tablets, creams, oral solutions, and injectable formulations across multiple therapeutic areas.

ICE Pharma (Industria Chimica Emiliana) is an Italian integrated pharmaceutical company with over 70 years of experience and 1,500 employees worldwide. The company is a leading global producer of Ursodeoxycholic acid (UDCA) and bile acid derivatives, offering CDMO services for solid and liquid finished dosage forms and complex carbohydrates. ICE Pharma operates 7 manufacturing facilities across North and South America, Europe, Asia, and Oceania.

Industria Quimica y Farmaceutica VIR, S.A.

Spain

Industria Quimica y Farmaceutica VIR, S.A. (Laboratorios VIR) is a Spanish pharmaceutical company based in Alcorcon. The company is FDA-registered and has been FDA-inspected (3 inspections, most recently September 2025). Limited information is available about their specific manufacturing capabilities, but they appear to be involved in pharmaceutical manufacturing and distribution.

JEWIM Pharmaceutical (Shandong) Co., Ltd. is a Chinese pharmaceutical company in transformation, focusing on innovative drugs and complex drug delivery systems including inhalation products, nasal sprays, and long-acting injectable microspheres. The company is an established CDMO/CMO partner for multinational pharma companies including Johnson & Johnson (Xian Janssen), Kenvue, and Bayer, with quality systems certified by US FDA and Australian TGA. Products are exported to over 80 countries.

KLEVA PHARMA (M.J. Kleva SA)

Greece

KLEVA Pharmaceuticals S.A. is a Greek pharmaceutical company established in 1974, specializing in contract manufacturing and technology transfer services. They operate two manufacturing sites in Greece, including a sterile area with filling capability expanded in 2019. KLEVA holds ISO 9001:2015 and EU GMP certification. Their R&D department develops generic pharmaceutical dossiers in CTD format, from patent search and API sourcing through formulation development, pilot-scale batches, stability studies, and dossier compilation. They have 190 marketing authorizations across Europe, Asia, Oceania, and Africa, serving over 50 customers in 30+ countries since 2012.

KLOCKE GRUPPE

Germany

KLOCKE Gruppe is a leading European contract manufacturer and contract packager of pharmaceuticals, medical devices, and nutritional supplements. They operate through two divisions: KLOCKE Pharma-Service (contract manufacturing of granules, tablets, film-coated tablets, dragees, hard capsules, and sachets) and KLOCKE Verpackungs-Service (contract packaging into cold and thermoformed blisters, bottles, and liquid filling). With 750 employees worldwide, over 60 years of family tradition, ~3,000 product items, and ~EUR 140M revenue, they are one of the largest pharmaceutical contract packagers in Europe. FDA-registered (3 FEI numbers) with operations in Germany.

Lavipharm

Greece

Lavipharm is a dynamic, international healthcare company listed on the Athens Stock Exchange since 1995, based in Greece. Their manufacturing plant is one of the few pharmaceutical manufacturing sites in Europe with fully integrated production lines, including dedicated lines for transdermal drug delivery systems (TDDS). The production facility covers 8,000 m2 and produces tablets, capsules, transdermal systems, oral liquids, creams, and ointments under strict GMP conditions. Lavipharm collaborates with FAMAR for contract manufacturing and has launched the first locally produced medical cannabis prescription product in Greece. They also partner with other companies for manufacturing services.

Lee Pharma Limited

India

Lee Pharma Limited is an Indian pharmaceutical company established in 1997 in Hyderabad, focused on the development, synthesis, and commercialization of Active Pharmaceutical Ingredients (APIs), intermediates, semi-finished dosage forms (pellets and granules), and finished formulations. Manufacturing facilities are approved by USFDA, EUGMP, and WHO GMP. Listed on CPHI Online as a CMO/CDMO and manufacturer. Serves partners in 30+ countries with a focus on Europe and Asia. Also has a CDMO services page and offers contract manufacturing services.

Lupin Limited (Lupin Manufacturing Solutions)

Brazil

Lupin Manufacturing Solutions (LMS) is the CDMO arm of Lupin Limited, one of India's largest pharmaceutical companies. LMS offers integrated CDMO services spanning API manufacturing, formulation development, and finished dosage form production. They operate 16 FDA-registered facilities with 512 FDA-approved products. They have recently expanded into oncology with a dedicated block at Vizag, India, and formed a strategic alliance with PolyPeptide for peptide supply chain scaling. Their extensive regulatory track record includes FDA, WHO, and multiple international approvals.

Marifarm proizvodnja in storitve d.o.o.

Slovenia

Marifarm d.o.o. is a Slovenian pharmaceutical company providing contract manufacturing services including finished dosage form manufacturing, project management, analytical services, logistics (GDP certified), herbal extract production, serialization systems, and microbiological quality control. The company is listed in pharmaceutical CMO industry databases and serves as a contract manufacturing partner for finished pharmaceutical products.

Medivant Healthcare

United States

Medivant Healthcare is a boutique, cGMP-compliant generic injectable manufacturer based in Chandler, Arizona, USA, founded in 2015. The company specializes in sterile single-dose liquid injectable vials (1 ml to 30 ml) for the US market, focusing on FDA/ASHP drug shortage list medications. Medivant operates an FDA-registered and inspected facility with a fully automated manufacturing tank (up to 240 liters under ISO 7 laminar flow), automated filling machine (up to 100 vials/minute under ISO 5), terminal sterilization with 10-log-6 overkill approach, and in-house WFI system. They serve over 300 hospitals and 10+ clinics. Medivant has a strategic partnership with Piramal Critical Care for injectables.

Mipharm S.p.A

Italy

Mipharm S.p.A. is a Milan-based pharmaceutical CDMO and one of the largest pharma CDMO sites in Italy. The company specializes in contract development and manufacturing of pharmaceutical products including production, packaging, R&D, and clinical trial logistics. 20% of staff is dedicated to quality. FDA-inspected (6 inspections, 1 NAI, 5 VAI).

MoNo chem-pharm Produkte GmbH

Austria

MoNo chem-pharm Produkte GmbH is an Austrian pharmaceutical contract manufacturer founded in 2000, affiliated with Sigmapharm Arzneimittel GmbH (70+ years in healthcare). The company specializes in the development and production of all types of pharmaceutical liquids — sterile and non-sterile, aqueous, oily, alcoholic, and viscous. State-of-the-art facilities for aseptic production of sterile liquids and filling into vials. Listed on CPHI for contract manufacturing, logistics/distribution, and regulatory services.

Montage Laboratories Private Limited

India

Montage Laboratories Private Limited is an Indian pharmaceutical formulations manufacturer based in Himatnagar, Gujarat with 30+ years of experience. The company specializes in sex hormone formulations and injectables, with dedicated facilities for sex hormone injection manufacturing (ampoules, vials, pre-filled syringes) and both beta-lactam and general injectable production. FDA-registered with 3 FEI numbers and 14 FDA inspections (12 NAI, 2 VAI — excellent track record). ISO 9001:2015 and ISO 14001:2015 certified, D&B certified.

Murli Krishna Pharma Pvt Ltd

India

Duplicate entry for Murli Krishna Pharma Private Ltd. (mkppl.com) - same company, same website domain. Indian pharmaceutical CDMO specializing in PFI and FDF products with CRAMS services.

Norwich Pharmaceuticals (now Norwich Pharma Services, part of Alvogen) is a US-based contract development and manufacturing organization with over 130 years of pharmaceutical manufacturing history in Norwich, New York. The company manufactures generic medications including capsules, tablets, and extended-release tablets. Norwich is FDA-registered with operations including analysis, labeling, manufacturing, packing, relabeling, and repacking, and has 3 FDA-approved products with strong inspection history (6 NAI out of 7).

Oakwood Laboratories LLC is a US-based specialty pharmaceutical company and CDMO focused on advanced injectable drug delivery systems, particularly sustained-release and microsphere formulations. The company operates a GMP aseptic manufacturing facility in Solon, Ohio, providing contract development and manufacturing for long-acting injectable products.

Olpha (formerly Olainfarm JSC) is the leading pharmaceutical manufacturer in Latvia with over 50 years of experience and approximately 850 employees. The company produces finished dosage forms, active pharmaceutical ingredients, and intermediates across 10 therapeutic groups with a portfolio of more than 60 drug forms and 25 APIs. Olpha offers contract manufacturing and pharmaceutical co-development services, and exports to more than 60 markets. The company recently rebranded and aims to become a European top 10 pharmaceutical company.

Onko Ilac Sanayi ve Ticaret A.S. is a Turkish pharmaceutical company offering contract manufacturing and out-licensing services. The company manufactures finished dosage form pharmaceutical products including oncology drugs (fingolimod, pemetrexed, temozolomide, abiraterone) and other therapeutic areas, exhibiting regularly at CPHI events.

Pace Life Sciences is a division of Pace Analytical Services LLC, operating as a full-service CDMO/CRO network across the United States. The company supports drug development across the entire lifecycle from preclinical research through commercialization, specializing in small molecules, biologics (proteins, peptides, monoclonal antibodies, ADCs), nucleic acids (oligonucleotides, mRNA, plasmid DNA), and gene therapies. Recognized by PharmaSource as a Top CDMO in the United States. Operates 9+ strategically located sites including a sterile fill-finish Center of Excellence in Salem, NH.

PharmIdea is a Latvian CDMO located in Olaine, Latvia, specializing in sterile drug development, commercial production, and worldwide supply of pharmaceutical products. The company focuses on sterile drugs in vials, offering contract manufacturing services including product development. PharmIdea has completed CTDs for out-licensing and provides contract manufacturing of sterile injectables such as Levosimendan concentrate for solution for infusion (small batch), Caspofungin, and Carbetocin. The company has partnered with Lidds for manufacturing NZ-TLR9 formulation against solid tumors.

Piramal Pharma Solutions (PPS) is a global CDMO under Piramal Pharma Limited, offering end-to-end development and manufacturing solutions across the drug lifecycle. Operates through a globally integrated network of 17 development and manufacturing facilities across North America, Europe, and Asia, with distribution in 100+ countries. Services include drug discovery, process/pharmaceutical development, clinical trial supplies, and commercial supply of APIs and finished dosage forms. Specialized in highly potent APIs, antibody-drug conjugations, sterile fill/finish, and peptide products. Multiple CDMO Leadership Award winner.

Recordati is an Italian pharmaceutical company with both a proprietary product business (rare diseases, specialty/primary care) and a fine chemicals/CDMO division. Recordati Fine Chemicals (also known as Recordati Industria Chimica e Farmaceutica) provides contract API manufacturing. They have FDA-registered facilities, 26 approved products across multiple dosage forms, and significant industrial operations. The fine chemicals division offers API development and manufacturing services to third-party pharmaceutical companies.

Reliance Life Sciences (RLS), part of Reliance Industries, is a premier Indian biotechnology company providing contract manufacturing and development services across pharmaceuticals and biosimilars. They have FDA-registered manufacturing facilities with 7 FDA-approved products (injectables, powders, tablets). Their capabilities span API manufacturing, formulation development, biologics/biosimilar manufacturing, and cell and gene therapy R&D. They are a vertically integrated biotech company with 1,000-5,000 employees, offering CDMO services alongside their own product portfolio.

Rontis

Greece

Rontis Corporation is a healthcare company headquartered in Zug, Switzerland with manufacturing operations including a pharmaceutical manufacturing facility in Larissa, Greece (FDA-registered, FEI 3002957541) and contract manufacturing operations in Veles, North Macedonia. The company is primarily known as a medical device and pharmaceutical manufacturer, with contract manufacturing as a secondary activity. Rontis supplies generics and operates in global markets with approximately $144.7 million in revenue.

Seda Pharma Development Services Ltd

United Kingdom

Seda Pharma Development Services Ltd is a UK-based pharmaceutical development consultancy and clinical manufacturing services provider. Through its subsidiary Seda Clinical Manufacturing Services (MHRA-licensed), the company provides formulation development, clinical pharmacology, DMPK, modelling, and GMP manufacturing of clinical trial materials. The company focuses on product design, performance prediction, and clinical supply.

SEDICO Pharmaceutical Company is an Egypt-based pharmaceutical manufacturer and API producer, providing contract manufacturing (CMO/CDMO) services. The company manufactures a broad range of pharmaceutical products including oral solids, injectables, and various dosage forms. SEDICO has recently entered oncology drug production through a partnership with Sandoz Global to localize oncology pharmaceutical products in Egypt.

Softigel (by Procaps Group)

Brazil

Softigel, a subsidiary of Procaps Group, is a CDMO headquartered in Brazil specializing in the development and manufacturing of soft gelatin capsules (softgels). With over 4 decades of experience, 7 manufacturing plants across the Americas, and 8+ patented softgel technologies, the company has developed 500+ products and has presence in 50+ countries.

DUPLICATE ENTRY: This is the same company as Standard Chem. & Pharm. Co. Ltd (companyId: 6a650983). See primary entry for full profile. Standard Chem. & Pharm. Co., Ltd. (SCP) is a Taiwanese CDMO established in 1967.

STA Pharmaceutical Co., Ltd. (WuXi STA) is a subsidiary of WuXi AppTec and one of the world's leading CDMOs, specializing in integrated CMC services for small molecule APIs and drug products (oral and injectable/sterile) from preclinical to commercial scale. They also have capabilities in oligonucleotides, peptides, and bioconjugates. WuXi STA operates 9-14 global manufacturing sites across Asia, North America, and Europe with uniform quality/EHS standards approved by major regulators. They have supported 50+ first-time drug approvals since 2017 across 105 countries. The company has 5,100+ scientists, claims 100% PPQ success rate, and serves 1,200+ customers. Their Changzhou site has passed US FDA inspection and they have a continuous manufacturing line for oral solid dose.

Stason Pharmaceuticals, Inc. is a US-based pharmaceutical company headquartered in Irvine, California, with CDMO services provided through its affiliate Western PharmSci. The company operates in both branded/generic pharmaceuticals and contract services. Their CDMO capabilities include turn-key drug development and manufacturing for oral solid dosage forms with particular expertise in high containment products (OEL down to 0.1 ug/m3) for oncology, CNS, and other potent compounds. Services span from pre-formulation characterization and API synthesis through commercial production (up to 600 kg), including analytical method development/validation, formulation development, clinical trial materials, and serialization. They hold 30+ ANDAs and have operations in 13 locations across 9 countries. Note: FDA issued a warning letter on July 8, 2020, citing significant CGMP violations for finished pharmaceuticals.

Sunny Pharmtech Inc. is a Taiwan-headquartered integrated specialty pharmaceutical CDMO specializing in high-potency APIs and drugs, including small molecules, peptides, and ADC linker-payloads. The company develops complex, high-barrier, niche drugs including ANDAs and 505(b)(2) filings, with state-of-the-art facilities offering OEB 5 containment and capabilities from early-stage formulation development to commercial manufacturing.

US-based topical and transdermal pharmaceutical CDMO, now merged with MedPharm (Durham, NC). Provides end-to-end services from formulation development through commercial manufacturing for topical, transmucosal, and transdermal drug products. Specializes in semi-solids, aerosols, liquids, injections, and transdermal patches. Offers in-vitro permeation testing (IVPT), in-vitro release testing (IVRT), disease activity models, tissue protein binding, and continuous flow technologies. GMP-certified manufacturing for generics, OTC, and prescription products.

Chinese pharmaceutical manufacturer specializing in corticosteroid, hormone, and steroid API production. Subsidiary of Shanghai Pharmaceuticals (Shanghai Xinyi Pharmaceutical Factory). Founded in 1992, located in Tianjin with approximately 170,000 sq meters across two factory areas and 507 employees. Main products include hydrocortisone, spironolactone, hydrocortisone acetate, clobetasol propionate, and related corticosteroid APIs. Also produces tablet formulations (9 approved products). Has 11 API production licenses and 9 tablet production licenses. FDA-registered with 3 FEI numbers, 13 inspections (4 NAI, 8 VAI, 1 OAI), and 2 FDA-approved finished dosage form products.

Unither Pharmaceuticals is a global CDMO specializing in sterile and non-sterile liquid pharmaceutical forms, and the world leader in Blow-Fill-Seal (BFS) technology with annual production capacity exceeding 5 billion doses. Founded in 1993 in France, they operate 9 production sites across Europe, North America, South America, and China with 2,500+ employees. They offer contract manufacturing (clinical and commercial), formulation/analytical development, out-licensing of turnkey products, co-development partnerships, and regulatory support including CTD/eCTD submissions. Products include BFS single-doses, multi-doses, vials, sprays, stick packs, and ophthalmic solutions.

Velesco Pharma (Pace Life Sciences)

United States

Velesco Pharmaceutical Services, now part of Pace Life Sciences (acquired by Pace Analytical), is a U.S.-based pharmaceutical CDMO specializing in drug development services. Per search results and industry listings, they provide analytical drug development, drug formulation, and pharmaceutical CDMO services. The acquisition by Pace Life Sciences expanded their capabilities in drug development services. The website (velescopharma.com) was blocked by Cloudflare security at scrape time, so detailed capability information is limited. They are listed on PharmaSource and CMOCRO as a CDMO.

Wanbang Biopharmaceuticals is a Chinese pharmaceutical manufacturer based in Xuzhou, Jiangsu province, specializing in the development, manufacture, and sale of pharmaceutical products. The company has FDA registration and produces products including capsules and APIs such as Febuxostat and Apixaban.

Zambon is an Italian multinational healthcare group founded in 1906 with EUR 899 million in revenues and 2,768 employees. The group operates as both a pharmaceutical company (Zambon Pharma) and a CDMO, offering contract development and manufacturing services ranging from development through commercial production. Manufacturing plants in Vicenza (Italy), Cadempino (Switzerland), Haikou (China), and Barueri (Brazil) supply 87 countries. Also includes Zach System (API custom synthesis) as its chemical division.

Zhejiang Hisoar Pharmaceutical Co., Ltd. (stock code 002099, Shenzhen Exchange), founded in 1966 and headquartered in Taizhou, Zhejiang, China, is a diversified pharmaceutical and chemical company with ~3,000 employees and 426 R&D personnel. Their pharmaceutical division produces specialty APIs, intermediates, formulations, and fine chemicals -- specifically antibiotics (penem/carbapenem series, clindamycin series), cardiovascular agents, and anti-diabetic APIs. Over 70% of products are exported. They also have a major dye/pigment business segment (~70% global market share in Reactive Blue KN-R). The company has 3 FDA-registered FEI numbers for API manufacture, 7 FDA inspections (4 NAI, 3 VAI, 0 OAI), 2 FDA-approved products (capsule, tablet), 40+ invention patents, and partnerships with Boehringer Ingelheim, Merck, Sanofi, Novartis, GSK, and others. Classified as API manufacturer because the core pharma business is own-brand API and intermediate production with limited CDMO positioning, though PharmaSource lists them under CMO/CDMO.

Aurisco Pharmaceutical Co., Ltd. is a CRDMO (contract research, development and manufacturing organization) headquartered in Taizhou, Zhejiang, China, specializing in generic and complex APIs and finished dosage forms. The company focuses on small-molecule drugs, peptide therapeutics, and oligonucleotide pharmaceuticals. Aurisco operates 4 manufacturing sites and 5 R&D centers in China with 1,500+ staff, has passed 5 cGMP inspections in 2023 (USFDA, EUGMP, PMDA, NMPA, KFDA), and is expanding peptide manufacturing capacity. Their steroid product portfolio includes abiraterone acetate and complex hormone formulations.

Berko Pharmaceuticals is a Turkish pharmaceutical company involved in the development, manufacturing, and marketing of pharmaceutical products including solid dosage forms and suppositories. Listed on CPHI as a CDMO specializing in development and manufacturing, with FDA-registered facilities and a long track record of FDA-inspected production (2 NAI inspections). Also has 27 FDA recalls on record, indicating substantial US market supply history.

Chanelle Pharma is Ireland's largest indigenous pharmaceutical manufacturer producing both human health and veterinary products. The company operates 4 manufacturing facilities with 550 employees, holding 1,200+ human health licenses, and provides contract manufacturing services for B2B pharmaceutical customers. Chanelle Pharma was acquired by the private equity firm Exponent and has appointed a new CEO to drive international growth, with manufacturing plants in Ireland and near Rome, Italy.